Literature DB >> 6690006

The association of pathologic and mammographic characteristics of primary human breast cancers with "slow" and "fast" growth rates and with axillary lymph node metastases.

L S Heuser, J S Spratt, J G Kuhns, A F Chang, H C Polk, J B Buchanan.   

Abstract

This article reports statistically significant associations existing between the clinical, mammographic and histopathologically classified properties of mammary cancers occurring in the population of 10,120 women screened in the BCDDP at the University of Louisville over a 5-year period and the propensity to grow "fast" and "slow" and metastasize or not metastasize to the axillary lymph nodes. Fast cancers, divided into two defined subsets as "fast 1" and "fast 2," are those surfacing in the intervals between mammograms. The faster cancers exhibited a significant absence of calcification, were discovered in younger patients and resulted in a shorter 5-year cumulative survival rate (fast 1 = 74 +/- 9% to slow = 94 +/- 4%). In addition to growth rates, another index of virulence in small cancers is the early appearance of metastases in the axillary lymph nodes. The absence of microscopic calcifications and the presence of lymphatic invasion around the primary cancer site were significantly associated with the presence of axillary metastases. Other factors associated with the occurrence of axillary metastases were a higher mitotic index, poor cellular differentiation and a larger size of cancer at diagnosis. The author's results confirm that interval surfacing cancers are biologically different and are not comparable to cancers discovered by scheduled screens. Cancers that metastasize to lymph nodes while very small have properties in common with these interval surfacing and, presumably, faster growing cancers.

Entities:  

Mesh:

Year:  1984        PMID: 6690006     DOI: 10.1002/1097-0142(19840101)53:1<96::aid-cncr2820530117>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

Review 1.  Review of general surgery 1984-85.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1985-11       Impact factor: 2.401

2.  Assessment of malignancy potential in so-called interval mammary carcinomas.

Authors:  A von Rosen; K Erhardt; L Hellström; A Somell; G Auer
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

3.  Breast cancer in women under 30 years of age.

Authors:  F Tabbane; A el May; M Hachiche; J Bahi; M Jaziri; M Cammoun; N Mourali
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

4.  Analysis of interval breast carcinomas in a randomized screening trial in Stockholm.

Authors:  J Frisell; G Eklund; L Hellström; A Somell
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

5.  Interval cancer and survival in a randomized breast cancer screening trial in Stockholm.

Authors:  J Frisell; A von Rosen; M Wiege; B Nilsson; S Goldman
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

6.  The epidemiological profile of women with an interval cancer in the DOM screening programme.

Authors:  C T Brekelmans; P H Peeters; J A Faber; J J Deurenberg; H J Collette
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 7.  The biology and natural history of breast cancer from the screening perspective.

Authors:  L Holmberg; J Pontén; H O Adami
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

8.  Machine learning-based prediction of breast cancer growth rate in vivo.

Authors:  Shristi Bhattarai; Sergey Klimov; Mohammed A Aleskandarany; Helen Burrell; Anthony Wormall; Andrew R Green; Padmashree Rida; Ian O Ellis; Remus M Osan; Emad A Rakha; Ritu Aneja
Journal:  Br J Cancer       Date:  2019-08-09       Impact factor: 7.640

9.  In Vivo Tumor Growth Rate Measured by US in Preoperative Period and Long Term Disease Outcome in Breast Cancer Patients.

Authors:  Tae-Kyung Yoo; Jun Won Min; Min Kyoon Kim; Eunshin Lee; Jongjin Kim; Han-Byoel Lee; Young Joon Kang; Yun-Gyoung Kim; Hyeong-Gon Moon; Woo Kyung Moon; Nariya Cho; Dong-Young Noh; Wonshik Han
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.